Bridges to the Baccalaureate Program (R25) National Institute of General Medical Sciences

60703 PAR-17-210 25-Sep-2017 1,500,000.00 USD
Program URL https://grants.nih.gov/grants/guide/pa-files/PAR-17-210.html
Deadline Dates (ALL) 25-Sep-2017, 25-Sep-2018
Synopsis  

National Institute of General Medical Sciences (NIGMS) invites applications that propose research education activities in the mission areas of the NIH.  The over-arching goal of this National Institute of General Medical Sciences (NIGMS) R25 program is to support educational activities that enhance the diversity of the biomedical research workforce. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development, Research Experiences, and Curriculum or Methods Development. A program application must include each activity, and describe how they will be synergized to make a comprehensive program. The Bridges to Baccalaureate Program is intended to provide these activities to community college students to increase transition to and completion of Bachelor’s degree in biomedical sciences. This program requires partnerships between community colleges or other two-year post-secondary educational institutions granting the associate degree with colleges or universities that offer the baccalaureate degree. Additionally, recruitment and retention plans are required as part of the application. This program will use the NIH Research Education (R25) grant mechanism.

| Leave a comment

Caplan Foundation for Early Childhood Invites Letters of Intent

The Caplan Foundation for Early Childhood supports innovative, creative projects and programs with potential to significantly enhance the development, health, safety, education, and/or quality of life of children from infancy through five years of age.

The foundation provides funding in the areas of early childhood welfare, early childhood education and play, and parenting education.

1) Early Childhood Welfare: Children can only reach their full potential when all aspects of their development — intellectual, emotional, and physical — are optimally supported. Providing a safe and nurturing environment for infants and preschoolers is essential, as is imparting to them the skills of social living in a culturally diverse world. To that end, the foundation supports programs that research best child-rearing practices and identify models that can provide creative, caring environments in which all children can thrive.

2) Early Childhood Education and Play: Research shows that children need to be stimulated and nurtured early in life if they are to succeed in school, work, and life. Such preparation relates to every aspect of a child’s development, from birth to age 5, and everywhere a child learns — at home, in childcare settings, and in preschool. The foundation seeks to improve the quality of both early childhood teaching and learning through the development of innovative curricula and research-based pedagogical standards, as well as the design of imaginative play materials and learning environments.

3) Parenting Education: To help parents create nurturing environments for their children, the foundation supports programs that teach parents about developmental psychology, cultural child-rearing differences, pedagogy, issues of health, prenatal care and diet, and programs that provide both cognitive and emotional support to parents.

Letters of Intent must be received no later than September 30, 2017. Upon review, selected applicants will be invited to submit a full application.

See the Caplan Foundation website for complete program guidelines and application procedures.

| Leave a comment

NIH Program Announcements

  • Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) – U.S. Entity (Admin Supplement)
    (PA-17-326)
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Center for Complementary and Integrative Health
    National Institute on Aging
    National Institute of Biomedical Imaging and Bioengineering
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Environmental Health Sciences
    National Institute of Mental Health
    Application Receipt/Submission Date(s): September 18, 2017; September 18, 2018; September 18, 2019, by 5:00 PM local time of applicant organization, by 5:00 PM local time of applicant organization.
  • NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp)
    (PA-17-328)
    National Institute of Mental Health
    Application Receipt/Submission Date(s): NIMH accepts and reviews applications on a continuous basis until April 1 of each fiscal year. Applications received after April 1 will be considered for funding in the next fiscal year. Earlier submission is strongly encouraged. Applications for FY 18 funds should be submitted no later than April 1, 2018. Applications for FY 19 funds should be submitted no later than April 1, 2019. Applications for FY 20 funds should be submitted no later than April 1, 2020 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)
    (PA-17-330)
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01)
    (PAR-17-327)
    National Institute of Mental Health
    Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • NIAID Physician-Scientist Pathway to Independence Award (K99/R00)
    (PAR-17-329)
    National Institute of Allergy and Infectious Diseases
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)
    (PAR-17-331)
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Small Grants on Primary Immunodeficiency Diseases (R03)
    (PAR-17-332)
    National Institute of Allergy and Infectious Diseases
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)
(PAR-17-333)
National Institute of Allergy and Infectious Diseases
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates

| Leave a comment

NIH Requests for Applications

  • Central Neural Mechanisms of Age-Related Hearing Loss (R01)
    (RFA-AG-18-017)
    National Institute on Aging
    National Institute on Deafness and Other Communication Disorders
    Application Receipt Date(s): November 8, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • BRAIN Initiative: New Concepts and Early – Stage Research for Large – Scale Recording and Modulation in the Nervous System (R21)
    (RFA-EY-17-002)
    National Eye Institute
    National Center for Complementary and Integrative Health
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): October 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Re-Competition of Global Network for Womens and Childrens Health Research (UG1)
    (RFA-HD-18-009)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): November 27, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • CAPSTONE Centers for Multidisciplinary Research in Child Abuse and Neglect (P50)
    (RFA-HD-18-012)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): November 27, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • The NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL) (U24)
    (RFA-HG-17-011)
    National Human Genome Research Institute
    Application Receipt Date(s): November, 9, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Tobacco Regulatory Science Small Grant Program for New Investigators (R03)
    (RFA-OD-17-012)
    National Institutes of Health
    U.S. Food and Drug Administration, Center for Tobacco Products
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    National Institute of Environmental Health Sciences
    Office of Disease Prevention
    Application Receipt Date(s): September 18, 2017, February 13, 2018, July 17, 2018, February 13, 2019 ), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Tobacco Regulatory Science (R01)
    (RFA-OD-17-013)
    National Institutes of Health
    U.S. Food and Drug Administration, Center for Tobacco Products
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    National Institute of Environmental Health Sciences
    Office of Disease Prevention
    Application Receipt Date(s): September 18, 2017, February 13, 2018, July 17, 2018, February 13, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Tobacco Regulatory Science (R21)
(RFA-OD-17-014)
National Institutes of Health
U.S. Food and Drug Administration, Center for Tobacco Products
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Office of Disease Prevention
Application Receipt Date(s): September 18, 2017, February 13, 2018, July 17, 2018, February 13, 2019 ), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

| Leave a comment

NIH Notices

  • HHS Small Business Innovation Research (SBIR) Program Contract Solicitation (PHS 2018-1) Now Available
    (NOT-OD-17-089) National Institutes of Health
  • Notice to Expire the “Tobacco Regulatory Science (R01)” RFA-OD-17-007
    (NOT-OD-17-091) National Institutes of Health
  • Notice to Expire the “Tobacco Regulatory Science Small Grant Program for New Investigators (R03)” RFA-OD-17-008
    (NOT-OD-17-092) National Institutes of Health
  • Notice to Expire the “Tobacco Regulatory Science (R21)” RFA-OD-17-009
    (NOT-OD-17-093) National Institutes of Health
  • Notice of Change in the Expiration Date for PAR-14-268 “International Research Collaboration on Alcohol and Alcoholism (U01)
    (NOT-AA-17-008)
    National Institute on Alcohol Abuse and Alcoholism
  • Notice of Early Expiration of PAR-15-281 “Multidisciplinary Studies of HIV and Aging (R03)”
    (NOT-AG-17-011)
    National Institute on Aging
    National Cancer Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute on Drug Abuse
    National Institute of Mental Health
  • Notice of NIA Participation in PAS-16-033 “Stimulating Hematology Investigation: New Endeavors (SHINE) (R01)” Aging and Hematopoiesis
    (NOT-AG-17-012)
    National Institute on Aging
  • Notice of NIA Participation in PAS-15-168 “New Directions in Hematology Research (SHINE-II) (R01)” Aging and Hematopoiesis
    (NOT-AG-17-013)
    National Institute on Aging
  • Notice of Clarification to the Award Budget for PAR-16-446 “NIAMS Clinical Trial Planning Grant (R34)
    (NOT-AR-17-018)
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • Notice of NCI’s Participation on PA-17-135, Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R01)
    (NOT-CA-17-069)
    National Cancer Institute
  • Notice of NCI’s Participation on PA-17-132, Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R21)
    (NOT-CA-17-070)
    National Cancer Institute
  • Notice of NCI’s Participation on PA-17-134, Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R03)
    (NOT-CA-17-071)
    National Cancer Institute
  • Notice of Change to the Eligibility of Foreign Components in PA-17-112, ” Neuroscience Research on Drug Abuse (R21)”
    (NOT-DA-17-042)
    National Institute on Drug Abuse
  • Notice of NIDA’s Participation in PAR-15-315 “Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21)”
    (NOT-DA-17-046)
    National Institute on Drug Abuse
  • Notice of NIDA’s Participation in PAR-16-330 “Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01)”
    (NOT-DA-17-047)
    National Institute on Drug Abuse
  • Notice of NIDA’s Participation in PAR-16-331 “Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01)”
    (NOT-DA-17-048)
    National Institute on Drug Abuse
  • Request for Information (RFI): Patient and Family Needs and Requirements to be Addressed by the Small Business Programs of the National Institute on Drug Abuse (NIDA)
    (NOT-DA-17-049)
    National Institute on Drug Abuse
  • Notice of Revised Reporting Requirement for Appointing Participants in PAR-17-209 “Bridges to the Doctorate (R25)”
    (NOT-GM-17-012)
    National Institute of General Medical Sciences
  • Notice of Revised Reporting Requirement for Appointing Participants in PAR-17-210 “Bridges to the Baccalaureate (R25)”
    (NOT-GM-17-013)
    National Institute of General Medical Sciences
  • Notice of Change: Requirement for use of xTrain by Grantees of “Bridges to the Doctorate (R25)” and “Bridges to the Baccalaureate (R25)” Programs
    (NOT-GM-17-014)
    National Institute of General Medical Sciences
  • Notice of Intent to Publish a Funding Opportunity Announcement for NIH Science Education Partnership Award (SEPA) (R25)
    (NOT-GM-17-015)
    National Institute of General Medical Sciences
  • Notice of Intent to Publish a Funding Opportunity Announcement for Programs to Increase Diversity among Individuals Engaged in Health Related Research (PRIDE) Summer Institutes (R25)
    (NOT-HL-17-527)
    National Heart, Lung, and Blood Institute
  • Notice of Intent to Publish a Funding Opportunity Announcement for Programs to Increase Diversity among Individuals Engaged in Health Related Research (PRIDE) Coordinating Center (U24)
    (NOT-HL-17-528)
    National Heart, Lung, and Blood Institute
  • Notice of Change to Key Dates for RFA-NS-17-024 “Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24)
    (NOT-NS-17-035)
    National Institute of Neurological Disorders and Stroke
  • Notice of Informational Webinar for the NINDS Parkinson’s Disease Biomarkers Program (PDBP) – PAR-16-112 (U01)
    (NOT-NS-17-036)
    National Institute of Neurological Disorders and Stroke
  • Notice of Change of the Review and Selection Process of RFA-RM-17-007 NIH Director’s Transformative Research Awards (R01)
    (NOT-RM-17-035)
    NIH Roadmap Initiatives
  • Request for Information: Opportunities and Challenges for Platform Vector Human Gene Therapy Trials in Rare Diseases
    (NOT-TR-17-019)
    National Center for Advancing Translational Sciences
  • Notice of Clarification to PAR-17-035 “Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)”
    (NOT-TR-17-020)
    National Center for Advancing Translational Sciences
  • Notice of Clarification to PAR-17-036: Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)
    (NOT-TR-17-021)
    National Center for Advancing Translational Sciences
  • Notice of Change to Key Dates for “Global Brain and Nervous System Disorders Research Across the Lifespan (R21)”
    (NOT-TW-17-006)
    John E. Fogarty International Center
    National Institute of Dental and Craniofacial Research
  • Notice of Change to Key Dates for “Global Brain and Nervous System Disorders Research Across the Lifespan (R01)”
    (NOT-TW-17-007)
    John E. Fogarty International Center
    National Eye Institute
    National Institute on Aging
    National Institute on Deafness and Other Communication Disorders
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    Office of Dietary Supplements
| Leave a comment

Department of Defense announcements

DOD
Department of Defense
Dept of the Army — Materiel Command
Distributed and Collaborative Intelligent Systems and Technology (DCIST) Collaborative Research Alliance (CRA) Synopsis 4

http://www.grants.gov/web/grants/view-opportunity.html?oppId=291951

DOD
Department of Defense
NAVAL FACILITIES ENGINEERING COMMAND
Stream Restoration NRL Cheasapeake Bay Detachment Synopsis 5

http://www.grants.gov/web/grants/view-opportunity.html?oppId=294141

| Leave a comment

Our Great Lakes regional office is available for support

Non-profits and Tribal organizations and Tribes are welcome to contact our Great L-&-D_logo.30Lakes office in Grand Rapids, MI for grantmaking and program evaluation support.

Checkout our web site for more information on our services at http://www.landd.net

Our send us a Tweet to @JillRGrantWrite or @landdnet

We specialize in health promotion and disease prevention, renewable energy, education, and Small Business Innovative Research proposals through the federal government.

Contact us to set up an appointment.

 

 

| Leave a comment
%d bloggers like this: